CAS 69-25-0

Eledoisin

Description:

Eledoisin is a peptide that is derived from the venom of the sea snail, specifically from the species Eledone moschata. It is classified as a neuropeptide and is known for its potent vasodilatory effects, which means it can cause blood vessels to widen, leading to a decrease in blood pressure. Eledoisin has a molecular formula that reflects its peptide structure, consisting of a sequence of amino acids linked by peptide bonds. This substance is of interest in pharmacology and biochemistry due to its potential therapeutic applications, particularly in cardiovascular research. Its mechanism of action involves interaction with specific receptors in the body, influencing various physiological processes. Additionally, Eledoisin has been studied for its effects on smooth muscle contraction and its role in modulating pain and inflammation. As with many peptides, its stability and bioavailability can be affected by factors such as enzymatic degradation and the route of administration. Overall, Eledoisin represents a fascinating area of study within the field of medicinal chemistry.

Formula: C₅₄H₈₅N₁₃O₁₅S

InChI: InChI=1/C54H85N13O15S/c1-7-30(4)44(53(81)57-27-42(70)60-36(24-29(2)3)49(77)61-33(45(56)73)20-23-83-6)66-50(78)37(25-32-14-9-8-10-15-32)63-46(74)31(5)58-48(76)38(26-43(71)72)64-47(75)34(16-11-12-21-55)62-51(79)39(28-68)65-52(80)40-17-13-22-67(40)54(82)35-18-19-41(69)59-35/h8-10,14-15,29-31,33-40,44,68H,7,11-13,16-28,55H2,1-6H3,(H2,56,73)(H,57,81)(H,58,76)(H,59,69)(H,60,70)(H,61,77)(H,62,79)(H,63,74)(H,64,75)(H,65,80)(H,66,78)(H,71,72)/t30-,31-,33-,34-,35-,36-,37-,38-,39-,40-,44-/m0/s1

SMILES: CC[C@H](C)[C@@H](C(=NCC(=N[C@@H](CC(C)C)C(=N[C@@H](CCSC)C(=N)O)O)O)O)N=C([C@H](Cc1ccccc1)N=C([C@H](C)N=C([C@H](CC(=O)O)N=C([C@H](CCCCN)N=C([C@H](CO)N=C([C@@H]1CCCN1C(=O)[C@@H]1CCC(=N1)O)O)O)O)O)O)O

Synonyms:

• Pyr-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2
• 5-Oxoprolylprolylseryllysyl-Alpha-Aspartylalanylphenylalanylisoleucylglycylleucylmethioninamide
• 5-oxo-L-prolyl-L-prolyl-L-seryl-L-lysyl-L-alpha-aspartyl-L-alanyl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl-L-methioninamide
• Eledosin Acetate

Eledoisin

CAS: 69-25-0

Formula: C₅₄H₈₅N₁₃O₁₅S

Purity: 98%

Molecular weight: 1188.3958

Ref: IN-DA01DQ7P

Eledoisin Acetate

CAS: 69-25-0

Ref: 7W-GX4185

Eledoisin

CAS: 69-25-0

Eledoisin (Eledone peptide) is a specific agonist of NK2 and NK3 receptors.Eledoisin is an undecapeptide of mollusk origin, belonging to the tachykinin family

Formula: C₅₄H₈₅N₁₃O₁₅S

Purity: 98%

Color and Shape: Solid

Molecular weight: 1188.4

Ref: TM-TP1177

Eledoisin Acetate

CAS: 69-25-0

Formula: C₅₄H₈₅N₁₃O₁₅S

Purity: 95%~99%

Color and Shape: White to Off-white Powder

Molecular weight: 1188.4

Ref: BP-BPPG024

Eledoisin

CAS: 69-25-0

Eledoisin

Molecular weight: 1,188.40g/mol

Ref: 54-BITP1538

Eledoisin

CAS: 69-25-0

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

Formula: C₅₄H₈₅N₁₃O₁₅S

Molecular weight: 1,181.41 g/mol

Ref: 3D-PP50539

Eledoisin acetate salt

CAS: 69-25-0

Eledoisin acetate salt is a cell-lysing agent that belongs to the group of potent antagonists. It is an inhibitor of neurokinin-1 receptor which regulates the release of substance P and other inflammatory mediators from nerve terminals. Eledoisin acetate salt has shown to inhibit locomotor activity in rats, as well as nucleotide levels in cells. This drug also has been shown to have carcinoid syndrome-like effects, such as weight loss and diarrhea. These symptoms are caused by the inhibition of substance P at its receptors. The tumor necrosis factor (TNF) may be responsible for these effects, since it causes increased production of substance P in cells.

Formula: C₅₄H₈₅N₁₃O₁₅S·xC₂H₄O₂

Purity: Min. 95%

Molecular weight: 1,188.4 g/mol

Ref: 3D-FE108742